Search Results
May 19, 2026, 18:22 ET Are KALV, GBTG, MDV, CPRX Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-kalv-gbtg-mdv-cprx-obtaining-fair-deals-for-their-shareholders-302776853.htmlSOURCE
More news about: Halper Sadeh LLP
May 14, 2026, 17:22 ET Are SILA, KALV, THR, LSTA Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-sila-kalv-thr-lsta-obtaining-fair-deals-for-their-shareholders-302772785.htmlSOURCE
More news about: Halper Sadeh LLP
May 08, 2026, 17:56 ET Are RMAX, KALV, GBTG Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-rmax-kalv-gbtg-obtaining-fair-deals-for-their-shareholders-302767289.htmlSOURCE
More news about: Halper Sadeh LLP
May 04, 2026, 14:55 ET Are XOMA, RMAX, KALV Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-xoma-rmax-kalv-obtaining-fair-deals-for-their-shareholders-302761531.htmlSOURCE
More news about: Halper Sadeh LLP
Apr 29, 2026, 18:39 ET Are KALV, TBRG, UNF, ESQ Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-kalv-tbrg-unf-esq-obtaining-fair-deals-for-their-shareholders-302757910.htmlSOURCE
More news about: Halper Sadeh LLP
Apr 29, 2026, 12:17 ET Shareholder Alert: Ademi LLP investigates whether KalVista Pharmaceuticals Inc. is obtaining a Fair Price for Public Shareholders
MILWAUKEE, April 29, 2026 /PRNewswire/ -- Ademi LLP is investigating KalVista (NASDAQ: KALV) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Chiesi Group.
More news about: Ademi LLP
Jan 14, 2026, 15:06 ET Multicare Pharma y KalVista Pharmaceuticals Anuncian Acuerdo para Llevar el Primer Tratamiento Oral a Demanda para el Angioedema Hereditario a América Latina
experiencia en la comercialización de terapias para enfermedades raras, anunció hoy un acuerdo de asociación con KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), una empresa biofarmacéutica global enfocada en el desarrollo de tratamientos innovadores para enfermedades raras. El acuerdo abarca Brasil, Argentina,
More news about: Multicare Pharma
Jan 13, 2026, 13:13 ET Multicare Pharma e KalVista Pharmaceuticals Anunciam Acordo para Levar o Primeiro Tratamento Oral Sob Demanda para Angioedema Hereditário à América Latina
experiência na comercialização de terapias para doenças raras, anuncia a assinatura de um acordo de parceria com a KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), companhia biofarmacêutica global focada no desenvolvimento de tratamentos inovadores para doenças raras. O acordo abrange Brasil, Argentina, Colômbia
More news about: Multicare Pharma
Nov 10, 2025, 08:00 ET Aaron's Transforms Race Weekend into Celebration of Customer Loyalty and Youth Opportunity
Club members. The young racing fans explored the Front Row Motorsports hauler during an exclusive tour, participated in a live remote broadcast with KALV-FM, and were surprised with a personal appearance by FRM driver Zane Smith, who signed autographs and shared insights about pursuing dreams in professional
More news about: The Aaron's Company, Inc.